Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Garima

      Articles By : Garima

      Roche extends Spark Therapeutics offer worth 4.3 billion USD

      Roche extends Spark Therapeutics' offer worth 4.3 billion USD

      Garima4 April 2019 9:14 AM IST
      Roche needs to get at least a majority of outstanding Spark stock for the offer to go through.ZURICH: Roche Holding has extended until May 2 its $4.3...
      Pfizer participates in SpringWorks Therapeutics USD125 million Series B financing

      Pfizer participates in SpringWorks Therapeutics' USD125 million Series B financing

      Garima3 April 2019 9:15 AM IST
      All of the SpringWorks Therapeutics' existing investors, OrbiMed, Bain Capital, Pfizer, via Pfizer Ventures, and LifeArc have also participated in the...
      Novartis to face lawsuit over doctor kickbacks

      Novartis to face lawsuit over doctor kickbacks

      Garima3 April 2019 9:10 AM IST
      The case began in 2011 as a whistleblower lawsuit filed by Oswald Bilotta, a former Novartis sales representative. Such lawsuits, brought under the...
      Jaslok Hospital to be likely taken over by IHH Healthcare: Report

      Jaslok Hospital to be likely taken over by IHH Healthcare: Report

      Garima2 April 2019 5:09 PM IST
      Mumbai: The bid among suitors to take over the operations of Mumbai-based Jaslok Hospital seems to have finally concluded with IHH Healthcare Berhad...
      Cipla signs over Rs 152 crore pact with Pulmatrix for new asthma drug Pulmazole

      Cipla signs over Rs 152 crore pact with Pulmatrix for new asthma drug Pulmazole

      Garima2 April 2019 9:45 AM IST
      The agreement has been signed between the company's wholly-owned subsidiary in the US, Cipla Technologies LLC with Pulmatrix Inc for investment in...
      Novartis to pay $310 million for assets from inflammation specialist IFM

      Novartis to pay $310 million for assets from inflammation specialist IFM

      Garima2 April 2019 9:00 AM IST
      IFM, whose research head Martin Seidel spent more than a decade at Novartis before assuming R&D duties at IFM in 2017, focuses on immune system...
      Next Generation of Technologies: Robots to assist people with disabilities

      Next Generation of Technologies: Robots to assist people with disabilities

      Garima1 April 2019 9:19 AM IST
      London: Scientists are developing robots to help reduce anxiety among children and allow families to 'visit' their elderly relatives, as part of a...
      Trump counts on courts to kill Obamacare

      Trump counts on courts to kill Obamacare

      Garima1 April 2019 9:18 AM IST
      If former President Barack Obama's health law is struck down entirely, Congress would face an impossible task: pass a comprehensive health overhaul to...
      Bayer Zydus Pharma to continue to invest in new medicines

      Bayer Zydus Pharma to continue to invest in new medicines

      Garima31 March 2019 10:00 AM IST
      The strong performance for multiple years speaks of the growing demand for its medicines to patients battling serious ailments such as cardiovascular...
      Philips India launches EPIQ Elite Ultrasound System

      Philips India launches EPIQ Elite Ultrasound System

      Garima30 March 2019 9:20 AM IST
      New Delhi, India: Enhancing clinical performance and patient experience, Royal Philips announced the launch of the EPIQ Elite ultrasound system, a new...
      New York sues billionaire family behind maker of OxyContin

      New York sues billionaire family behind maker of OxyContin

      Garima30 March 2019 9:00 AM IST
      NEW YORK: New York is suing the billionaire family behind the company that created OxyContin, joining a growing list of state and local governments...
      Suven Life Sciences secures Product Patent in Brazil, Eurasia

      Suven Life Sciences secures Product Patent in Brazil, Eurasia

      Garima29 March 2019 9:40 AM IST
      The granted claims of patents are being developed as therapeutic agents useful in treatment of cognitive impairment associated with neurodegenerative...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok